Actelion Pharmaceuticals Ltd
This supplement to The American Journal of Managed Care provides an overview of a retrospective claims database study with results showing that pulmonary arterial hypertension is characterized by long durations and high incurred costs of pulmonary hypertension— related hospitalizations and readmissions over 1 year.This study and supplement were sponsored by .
Faculty
James P. Burke, PhD
Senior Researcher
Health Economics and Outcomes
Research
Optum
Eden Prairie, Minnesota
Paul Buzinec, MS
Associate Director
Health Economics and Outcomes
Research
Optum
Eden Prairie, Minnesota
William Drake III, PharmD
Associate Director
Medical Managed Markets and
Health Economics and
Outcomes Research
Actelion Pharmaceuticals US, Inc
South San Francisco, California
Elke Hunsche, PhD
Senior Director
Global Market Access and Pricing
Actelion Pharmaceuticals Ltd
Allschwil, Switzerland
Mitchell Nagao, PharmD, MBA
Senior Director
Medical Affairs and Health
Economics and Outcomes
Research
Actelion Pharmaceuticals US, Inc
South San Francisco, California
Etienne Régulier, PhD
Associate Director
Global Market Access and Pricing
Actelion Pharmaceuticals Ltd
Allschwil, Switzerland
Faculty Disclosures
These faculty report relationships with the following organizations:
James P. Burke, PhD
Employment: Optum, which received funding from Actelion Pharmaceuticals Ltd for the research described in the present manuscript
Paul Buzinec, MS
Employment: Optum, which received funding from Actelion Pharmaceuticals Ltd for the research described in the present manuscript
William Drake III, PharmD
Employment and stock ownership: Actelion Pharmaceuticals US, Inc
Elke Hunsche, PhD
Employment and stock ownership: Actelion Pharmaceuticals Ltd
Mitchell Nagao, PharmD, MBA
Employment and stock ownership: Actelion Pharmaceuticals US, Inc
Etienne Régulier, PhD
Employment and stock ownership: Actelion Pharmaceuticals Ltd
Signed disclosures are on file at the office of The American Journal of Managed Care, Plainsboro, New Jersey.